{"id":428,"date":"2016-05-18T19:05:25","date_gmt":"2016-05-19T00:05:25","guid":{"rendered":"https:\/\/3sixtypharma.com\/?p=428"},"modified":"2016-05-20T11:13:47","modified_gmt":"2016-05-20T16:13:47","slug":"melanoma-drug-verge-breakthrough","status":"publish","type":"post","link":"https:\/\/3sixtypharma.com\/2016\/05\/18\/melanoma-drug-verge-breakthrough\/","title":{"rendered":"Jimmy Carter’s Melanoma drug on the verge of ?breakthrough?"},"content":{"rendered":"

\"Jimmy<\/a>In 2014, FDA gave pembrolizumab accelerated approval for melanoma.?<\/span><\/p>\n

Today, the 3-year survival rate in melanoma patients is reported to be 40%.? ASCO president Dr. Julie Vose told NBC News, “This is something really different than what we have seen in the past.” ?nbcnews.to\/25btTBv<\/span>?<\/span><\/span><\/a> via @<\/s>nbcnews<\/b><\/a>? @3SixtyPharma<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

In 2014, FDA gave pembrolizumab accelerated approval for melanoma.? Today, the 3-year survival rate in melanoma patients is reported to be 40%.? ASCO president Dr. Julie Vose told NBC News, “This is something really different than what we have seen in the past.” ?nbcnews.to\/25btTBv? via @nbcnews? @3SixtyPharma<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[8],"tags":[11,12],"class_list":["post-428","post","type-post","status-publish","format-standard","hentry","category-pharma-news","tag-3sixtypharma","tag-melanoma"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7wLmz-6U","jetpack_likes_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/posts\/428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/comments?post=428"}],"version-history":[{"count":0,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/posts\/428\/revisions"}],"wp:attachment":[{"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/media?parent=428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/categories?post=428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/3sixtypharma.com\/wp-json\/wp\/v2\/tags?post=428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}